Arovella Therapeutics Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 0.0085 million compared to AUD 0.379588 million a year ago. Revenue was AUD 2.03 million compared to AUD 1.44 million a year ago.

Net loss was AUD 3.95 million compared to AUD 3.9 million a year ago. Basic loss per share from continuing operations was AUD 0.0044 compared to AUD 0.0058 a year ago. Diluted loss per share from continuing operations was AUD 0.0044 compared to AUD 0.0058 a year ago.